Complement Therapeutics Ltd announced that it has received €72 million in a round of funding co-led by new investor Gimv NV and returning investor Forbion Capital Partners B.V. on April 17, 2023. The transaction included participation from new investors, Panakès Partners SGR SpA, Cambridge Innovation Capital Limited, Hadean Ventures, Seroba Life Sciences Limited and returning investor, BioGeneration Ventures B.V.